Benavides M, Antón A, Gallego J, et al. Biliary tract cancers: SEOM clinical guidelines. Clin Transl Oncol. 2015;17(12):982–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsukuma S, Tokumitsu Y, Shindo Y, Matsui H, Nagano H. Essential updates to the surgical treatment of biliary tract cancer. Ann Gastroenterol Surg. 2019;3(4):378–89.

Article  PubMed  PubMed Central  Google Scholar 

Thongprasert S, Napapan S, Charoentum C, Moonprakan S. Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol. 2005;16(2):279–81.

Article  CAS  PubMed  Google Scholar 

Yoshida K, Yamaguchi K, Okumura N, Tanahashi T, Kodera Y. Is conversion therapy possible in stage IV gastric cancer: the proposal of new biological categories of classification. Gastric Cancer. 2016;19(2):329–38.

Article  PubMed  Google Scholar 

Furuse J, Shibahara J, Sugiyama M. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer. J Hepatobiliary Pancreat Sci. 2018;25(5):261–8.

Article  PubMed  Google Scholar 

Kato A, Shimizu H, Ohtsuka M, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study. Ann Surg Oncol. 2013;20(1):318–24.

Article  PubMed  Google Scholar 

Addeo P, Rosso E, Fuchshuber P, et al. Double purse-string telescoped pancreaticogastrostomy: an expedient, safe, and easy technique. J Am Coll Surg. 2013;216(3):e27–33.

Article  PubMed  Google Scholar 

Noji T, Nagayama M, Imai K, et al. Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study. Surg Today. 2020;50(11):1409–17.

Article  PubMed  Google Scholar 

Oh MY, Kim H, Choi YJ, et al. Conversion surgery for initially unresectable extrahepatic biliary tract cancer. Ann Hepatobiliary Pancreat Surg. 2021;25(3):349–57.

Article  PubMed  PubMed Central  Google Scholar 

Slupski MW, Szczylik C, Jasinski MK. Unexpected response to systemic chemotherapy in case of primarily nonresectable advanced disseminated intrahepatic cholangiocarcinoma. World J Surg Oncol. 2007;5(1):36.

Article  PubMed  PubMed Central  Google Scholar 

Kato A, Shimizu H, Ohtsuka M, et al. Downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer patients treated with gemcitabine plus cisplatin combination therapy followed by radical surgery. Ann Surg Oncol. 2015;22(3):S1093–9.

Article  PubMed  Google Scholar 

Tran TB, Bal CK, Schaberg K, Longacre TA, Chatrath BS, Poultsides GA. Locally advanced intrahepatic cholangiocarcinoma: complete pathologic response to neoadjuvant chemotherapy followed by left hepatic trisectionectomy and caudate lobectomy. Dig Dis Sci. 2015;60(11):3226–9.

Article  PubMed  Google Scholar 

Matsubara T, Nishida T, Tomimaru Y, et al. Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: a case report. Mol Clin Oncol. 2016;5(6):757–61.

Article  PubMed  PubMed Central  Google Scholar 

Watanabe T, Furuse J, Okano N, Suzuki Y, Kamma H, Sugiyama M. A pathological complete response after combined chemotherapy of gemcitabine and S-1 in advanced biliary tract cancer with para-aortic lymph nodes metastasis: a case report. Surg Case Rep. 2017;3(1):26.

Article  PubMed  PubMed Central  Google Scholar 

Tatsuguchi T, Gotoh K, Kobayashi S, et al. Pathologic complete response after gemcitabine and S-1 chemotherapy for far advanced intrahepatic cholangiocarcinoma. Int Canc Conf J. 2018;7(3):93–7.

Article  Google Scholar 

Adachi K, Okuwaki K, Nishiyama R, et al. A case of extrahepatic bile duct cancer with distant metastases showing pathological complete response to treatment combining gemcitabine and cisplatin. Clin J Gastroenterol. 2019;12(5):466–72.

Article  PubMed  Google Scholar 

Abudalou M, Vega EA, Kondratiev S, Conrad C, Kozyreva O. Complete pathological response to neoadjuvant chemoimmunotherapy in a patient with metastatic intrahepatic cholangiocarcinoma with high tumor mutational burden. Cureus. 2021;13(12):e20187.

PubMed  PubMed Central  Google Scholar 

Sumiyoshi T, Uemura K, Shintakuya R, et al. A case of unresectable locally advanced intrahepatic cholangiocarcinoma that achieved pathological complete response after gemcitabine and S1 chemotherapy. Clin J Gastroenterol. 2022;15(6):1164–8.

Article  PubMed  Google Scholar 

Zhang X, Tang H, Fan J, et al. Case report: a report of the complete pathological response of intrahepatic cholangiocarcinoma after conversion therapy. Front Immunol. 2022;13:1051130.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shibata Y, Sudo T, Tazuma S, et al. Micro-lymph node metastasis in intrahepatic cholangiocarcinoma showing pathological complete response to primary tumor and intrahepatic metastasis treated by gemcitabine plus cisplatin chemotherapy and radical surgery. Clin J Gastroenterol. 2023;16(1):81–6.

Article  PubMed  Google Scholar 

Shimamaki Y, Hosokawa I, Takayashiki T, Takano S, Sonoda I, Ohtsuka M. Pathological complete response following neoadjuvant chemotherapy for locally advanced intrahepatic cholangiocarcinoma. Surg Case Rep. 2024;10(1):35.

Article  PubMed  PubMed Central  Google Scholar 

Burris HA 3rd, Okusaka T, Vogel A, et al. Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2024;25(5):626–35.

Article  CAS  PubMed  Google Scholar 

Ioka T, Kanai M, Kobayashi S, et al. Randomized phase III study of gemcitabine, cisplatin plus S-1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401- MITSUBA). J Hepatobiliary Pancreat Sci. 2023;30(1):102–10.

Article  PubMed  Google Scholar